Folkestad Lars, Brandt Frans, Brix Thomas, Vogsen Marianne, Bastholt Lars, Grupe Peter, Krogh Petersen Jeanette, Hegedüs Laszlo
Department of Endocrinology, Odense University Hospital, Odense, Denmark.
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Eur Thyroid J. 2017 Sep;6(5):276-280. doi: 10.1159/000479061. Epub 2017 Aug 3.
Graves disease (GD) is an autoimmune condition characterized by the presence of antibodies against the thyrotropin receptor (TRAB), which stimulate the thyroid gland to produce excess thyroid hormone. Theoretically, TRAB could stimulate highly differentiated thyroid cancer tissue and/or metastases to produce thyroid hormone.
A 68-year-old male, with weight loss and palpitations, was diagnosed with thyrotoxicosis. A later MRI, due to persistent shoulder pain, revealed multiple bone metastases. A biopsy was diagnostic for follicular variant of papillary thyroid carcinoma, and total thyroidectomy was performed. One week after thyroidectomy the patient was admitted with severe hyperthyroidism. TRAB was >40 IU/mL (normal <0.7 IU/mL). High-dose antithyroid drug treatment was followed by high-dose radioactive iodine-131 (RAI) and local radiotherapy covering the right shoulder. Antithyroid drug treatment continued until after the fourth RAI dose. Hypothyroidism did not occur until following the fifth RAI treatment.
We present a patient initially diagnosed with thyrotoxicosis and subsequently with metastatic follicular variant of papillary thyroid cancer. It is suggested that TRAB stimulated the highly differentiated extrathyroidal metastatic thyroid tissue to produce excessive amounts of thyroid hormone, delayed diagnosis, and potential aggravation of the course of thyroid cancer.
格雷夫斯病(GD)是一种自身免疫性疾病,其特征是存在针对促甲状腺激素受体(TRAB)的抗体,该抗体刺激甲状腺产生过量甲状腺激素。从理论上讲,TRAB可刺激高分化甲状腺癌组织和/或转移灶产生甲状腺激素。
一名68岁男性,有体重减轻和心悸症状,被诊断为甲状腺毒症。后来因持续的肩部疼痛进行了MRI检查,发现多处骨转移。活检诊断为甲状腺乳头状癌滤泡变异型,并进行了甲状腺全切术。甲状腺切除术后一周,患者因严重甲亢入院。TRAB>40 IU/mL(正常<0.7 IU/mL)。先采用高剂量抗甲状腺药物治疗,随后进行高剂量放射性碘-131(RAI)治疗及覆盖右肩部的局部放疗。抗甲状腺药物治疗持续至第四次RAI剂量之后。直到第五次RAI治疗后才出现甲状腺功能减退。
我们报告了一名最初诊断为甲状腺毒症,随后诊断为甲状腺乳头状癌滤泡变异型伴转移的患者。提示TRAB刺激高分化的甲状腺外转移甲状腺组织产生过量甲状腺激素,导致诊断延迟,并可能使甲状腺癌病程加重。